Related Experiment Video
Updated: Oct 10, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
The kinetic mechanism of 5-enolpyruvylshikimate-3-phosphate synthase from a gram-positive pathogen Streptococcus
1Anti-Infectives Research, SmithKline Beecham Pharmaceuticals, Collegeville, PA 19426, USA.
Abstract:
The Streptococcus pneumoniae 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase is a potential novel antibacterial target. The enzyme catalyzes a reversible transfer of an enolpyruvyl group from phospho(enol)pyruvate (PEP) to shikimate 3-phosphate (S3P) to give EPSP with the release of inorganic phosphate (Pi). Understanding the kinetic mechanism of this enzyme is crucial to the design of novel inhibitors of this enzyme that may have potential as antibacterial agents. Steady-state kinetic studies of product inhibition and inhibition by glyphosate (GLP) have demonstrated diverse inhibition patterns of the enzyme. In the forward reaction, GLP is a competitive inhibitor with respect to PEP, but an uncompetitive inhibitor relative to S3P. Product inhibition shows that EPSP is a competitive inhibitor versus both PEP and S3P, suggesting that the forward reaction follows a random sequential mechanism. In the reverse reaction, GLP is an uncompetitive inhibitor versus EPSP, but a noncompetitive inhibitor versus Pi. This indicates that a non-productive quaternary complex might be formed between the enzyme, EPSP, GLP and Pi. Product inhibition in the reverse reaction has also been investigated. The inhibition patterns of the S. pneumoniae EPSP synthase are not entirely consistent with those of EPSP synthases from other species, indicating that EPSP synthases from different organisms may adopt unique mechanisms to catalyze the same reactions.
Insights
Streptococcus pneumoniae EPSP synthase, a novel antibacterial target, exhibits unique kinetic inhibition patterns. Understanding its mechanism is key to developing new antibacterial agents.
Area of Science:
- Biochemistry
- Enzymology
- Drug Discovery
Background:
- Streptococcus pneumoniae 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase is a potential antibacterial target.
- The enzyme catalyzes a crucial step in the shikimate pathway, essential for bacterial survival.
Purpose of the Study:
- To elucidate the kinetic mechanism of S. pneumoniae EPSP synthase.
- To investigate inhibition patterns by glyphosate (GLP) and reaction products.
- To inform the design of novel antibacterial inhibitors.
Main Methods:
- Steady-state kinetic studies.
- Product inhibition assays.
- Enzyme inhibition by glyphosate.
Main Results:
- Glyphosate exhibits competitive inhibition with PEP and uncompetitive inhibition with S3P in the forward reaction.
- EPSP acts as a competitive inhibitor against both PEP and S3P, suggesting a random sequential mechanism.
- Inhibition patterns differ from other species, indicating unique enzymatic mechanisms.
Conclusions:
- S. pneumoniae EPSP synthase displays distinct kinetic properties compared to orthologs.
- These findings are critical for developing targeted antibacterial therapies against S. pneumoniae.
- The enzyme's unique mechanism may be exploited for selective drug design.
Related Concept Videos
ATP Synthase: Mechanism
ATP Synthase: Structure
Electron Transport Chain Components
Keto–Enol Tautomerism: Mechanism
ATP Energy Storage and Release
One example of energy coupling using ATP involves a...
Other Glycolytic Pathways

